Quan Tao1, Peiwei Yi1, Zimeng Cai1, Yingjie Mei2, Zhifeng Chen1, Ruiyuan Liu1, Wufan Chen1, and Yanqiu Feng1
1School of Biomedical Engineering, Southern Medical University, Guangzhou, China, 2Philips healthcare, Guangzhou, China
Synopsis
Chemical exchange saturation transfer (CEST) MRI has been
widely investigated for the early diagnosis of neurological diseases, such as
brain tumor and neurodegenerative disorders. The goal of this study was to
develop an imaging biomarker for the future intervention and treatment of PD in
clinic. For such purpose, a novel radial-sampling steady-state CEST sequence
based ultrashort echo time (UTE) readout was used to acquire the Z-spectrum in
the mouse brain of subacute PD model induced by MPTP.
Synopsis
Chemical exchange saturation transfer (CEST) MRI has been
widely investigated for the early diagnosis of neurological diseases, such as
brain tumor and neurodegenerative disorders. The goal of this study was to
develop an imaging biomarker for the future intervention and treatment of PD in
clinic. For such purpose, a novel radial-sampling steady-state CEST sequence
based ultrashort echo time (UTE) readout was used to acquire the Z-spectrum in
the mouse brain of subacute PD model induced by MPTP.Introduction
Parkinson’s
disease (PD) is a neurological disorder caused by degeneration of dopaminergic
neurons in substantia nigra and striatum, with cardinal symptom of dyskinesia
and resting tremor[1]. PD diagnosis and
severity evaluation are crucial for the disease treatment in clinic. Chemical
exchange saturation transfer (CEST) MRI is a novel molecular imaging technique
and sensitive to many endogenous labile protons, which has recently been
investigated for the early diagnosis of PD. Initial study in PD patient have
showed that CEST/APT signal could be an potential imaging biomarker[2]. In this study we
used a novel UTE-CEST sequence to acquire the Z-spectrum to detect the mobile
protein changes in subacute mouse model of PD treated by
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)[3][4]. Using a relatively
weak RF saturation amplitude, contributions due to strong magnetization
transfer contrast (MTC) from solid-like macromolecules and direct water
saturation (DS) were minimized. We suppose that such obtained imaging biomarker
may be better for the early diagnosis of Parkinson’s disease and the accurate
evaluation of disease severity.Methods
Animal experiment All
animals were performed under a protocal approved by our institutional animal
care and used committee. C57BL/6 WT mice (Center for experimental animals,
Southern Medical University, Guang Zhou, China) were given
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, Sigma M0896-30) by intraperitoneal
injection for six day (n=6, 25 mg/kg, soluted in saline), and control group
(n=6) were given the same volume of saline. Mouse were imaged two weeks after
the model become stable and then executed for pathological examination.
UTE-CEST All animals
were scanned on a 7 T small-bore MRI scanner (Bruker Biospec, Billerica, MA)
equipped with a mouse brain surface array RF coil (receiver) and a 72 mm volume
coil. All animal were anesthetized using 3% isoflurane and 1-2% maintenance.
The mouse head was positioned using a bite bar and two ear pins. A water-heated
animal bed was used to keep the temperature of mouse. UTE-CEST imaging was
conducted with Gaussian presaturated pulse, ultra short echo time readout and
radially fills the k-space. The duration of Gaussian saturation pulse was 30
ms, and the saturation power = 0.9 μT, repetition time (TR) = 40 ms,
effective echo time (TE) = 0.4 ms, slice thickness = 1.5 mm, nominal Cartesian
acquisition matrix size = 90 × 90, FOV = 15 × 15 mm2. Z-spectrum
acquired in the range of ±8 ppm, frequency step size is 0.1 ppm around the
-3.5, 0 and 3.5 ppm, and 0.5 ppm step size for another region of z-spectrum.
Histology/immunohistochemical
The
mouse brain were immediately fixed in 4% paraformaldehyde for 24h, embedded in
paraffin, coronal sections of the substantia nigra and striatum at a thickness
of 5 μm, then stained with hematoxylin–eosin (HE), and tyrosine
hydroxylase(TH).
Data processing The CEST
signal was subtracted by ΔST(±3.5ppm)=Z(8ppm)-Z(±3.5ppm).Result
Histology/immunohistochemical
Figure
1 show the tyrosine hydroxylase (TH) immunohistochemical staining for
substantia nigra (SNR), the staining of tyrosine hydroxylase were significantly
weakened, which proved the PD model induced by MPTP were established.
UTE-CEST In
figure 2, the z-spectrum of CPu, cx, cc, th and SNR in WT mouse were shown. Figure 3 (a) shows
the representative average z-spectrum of CPu from WT and PD mice, clearly
signal difference at 3.5 ppm between two sorts of mouse, figure 3 (b), (c),
(d), (e) show the NOE and APTw image of CPu in WT mice and PD mouse,
respectively. Similarly, figure 4 show the average z-spectrum, NOE and APTw image
of SNR. From figure 5, we have concluded that the APT signal in PD mice was
significantly different from in WT mice, both in the region of CPu and SNR, the
APT improved 24% (p<0.05) and 35% (p<0.001), respectively. In cx, cc and
th, the APT show no significant difference. NOE also be measured, but there
were no significant difference in these five region of brain between PD and WT
mouse.
T1 relaxation To
exclude the influenced by T1-weighted, T1 values was measured. The mean T1
values were 1.473±0.032 s and 1.459±0.052 s for Cpu in PD and WT mouse
(P=0.349), as for SNR, the mean T1 values were 1.280±0.062 s and 1.285±0.069 s
in the two group of mouse (P=0.849). There are also no significant difference
of T1 values in the cx, cc and th.Discussion and Conclusion
In
this study, we quantify the APT signal in PD mouse induced by MPTP,the APT
increase significantly, where the rNOE and T1 have not significant difference,
UTE readout improve the detection precision. It indicate CEST MRI is potential
method to detect the PD. However, MPTP induced PD model not on all full with in
clinical, further researchs are still needed to validate the mechanism of
Parkinson’s disease and the origination of the APT signal alteration in PD.Acknowledgements
This work was supported by the Guangdong Provincal Medical Foundation
(A2018268).References
[1]
Poewe W, Seppi K, Tanner C M, et al.
Parkinson disease[J]. Nature reviews Disease primers, 2017, 3: 17013.
[2]
Li C, Peng S, Wang R, et al. Chemical
exchange saturation transfer MR imaging of Parkinson’s disease at 3 Tesla[J].
European radiology, 2014, 24(10): 2631-2639.
[3]
Smeyne R J, Jackson-Lewis V. The MPTP
model of Parkinson's disease[J]. Molecular brain research, 2005, 134(1): 57-66.
[4]
Chen L, Wei Z, Chan K W Y, et al. Protein
aggregation linked to Alzheimer's disease revealed by saturation transfer
MRI[J]. NeuroImage, 2019, 188: 380-390.